This conference was established in 2001 and, held annually since then, alternates between Europe and the U.S. These truly global meetings are organized under the leadership of PDA in close cooperation with European regulatory agencies and the U.S. FDA. They provide an overview and updates on regulatory expectations and scientific investigations related to virus and TSE safety of biotechnology, plasma-derived and cell-derived medicinal products. As in previous years, virus contamination of raw materials as well as emerging viral threats will be discussed.
© Copyright 2008-2021 Semigator GmbH | Für die Richtigkeit der Angaben übernehmen wir keine Gewähr.